SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Synovus Financial Corp

Synovus Financial Corp boosted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 110.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,391 shares of the exchange traded fund’s stock after buying an additional 4,939 shares during the quarter. Synovus Financial Corp’s holdings in SPDR S&P Biotech ETF were worth $928,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after acquiring an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new stake in SPDR S&P Biotech ETF during the third quarter valued at $141,284,000. Affinity Asset Advisors LLC raised its holdings in shares of SPDR S&P Biotech ETF by 105.4% during the second quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock worth $3,481,000 after purchasing an additional 737,550 shares during the period. Mirae Asset Securities USA Inc. bought a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter worth about $55,626,000. Finally, Assetmark Inc. boosted its holdings in shares of SPDR S&P Biotech ETF by 72,653.0% in the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after buying an additional 588,489 shares during the period.

SPDR S&P Biotech ETF Stock Up 1.5 %

Shares of NYSEARCA:XBI opened at $94.76 on Tuesday. The firm has a 50-day simple moving average of $98.01 and a 200 day simple moving average of $97.17. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The company has a market cap of $7.22 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.